Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Acurx Pharmaceuticals Q3 2026 Results: Net Loss of $2.58M, Loss Widens

Acurx Pharmaceuticals reported a net loss of $6.5 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year period. The company strengthened its cash position to $9.7 million following equity issuances, while research and development expenses increased significantly in the third quarter to $1.1 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-2.6-2.0
EPS (diluted, $ a share)$-0.49$-1.23

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: ACXP. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Acurx Pharmaceuticals, Inc.: key numbers

Share price
$0.9350Close, Nov 16
Market cap
$5.66M
Shares outstanding
6.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Acurx Pharmaceuticals, Inc.

All →
4:32 PM ET 8-K
Leadership Change

Acurx Pharmaceuticals Leadership Change

Joseph C. Scodari, a member of the Board of Directors since 2021, notified Acurx Pharmaceuticals of his intention to retire from the Board effective November 13, 2026. His departure is not due to any disagreement with the company, and he has agreed to continue serving as a corporate advisor following his retirement.

4:31 PM ET 8-K
Shareholder Meeting

Acurx Pharmaceuticals Shareholder Meeting

Acurx Pharmaceuticals held its Annual Meeting of Stockholders on October 16, 2026, where shareholders elected David P. Luci and Jack H. Dean as Class II directors for three-year terms. Additionally, stockholders ratified the appointment of CohnReznick LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.